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The Suv39h1 and Suv39h2 H3K9 histone methyltransferases (HMTs) have a conserved role in the formation of
constitutive heterochromatin and gene silencing. Using a transgenic mouse model system we demonstrate that
elevated expression of Suv39h1 increases global H3K9me3 levels in vivo. More specifically, Suv39h1 overexpression
enhances the imposition of H3K9me3 levels at constitutive heterochromatin at telomeric and major satellite repeats in
primary mouse embryonic fibroblasts. Chromatin compaction is paralleled by telomere shortening, indicating that
telomere length is controlled by H3K9me3 density at telomeres. We further show that increased Suv39h1 levels result in
an impaired clonogenic potential of transgenic epidermal stem cells and Ras/E1A transduced transgenic primary mouse
embryonic fibroblasts. Importantly, Suv39h1 overexpression in mice confers resistance to a DMBA/TPA induced skin
carcinogenesis protocol that is characterized by the accumulation of activating H-ras mutations. Our results provide
genetic evidence that Suv39h1 controls telomere homeostasis and mediates resistance to oncogenic stress in vivo. This
identifies Suv39h1 as an interesting target to improve oncogene induced senescence in premalignant lesions.
Introduction
The H3K9 specific histone methyltransferases (HMTs)
Suv39h1 and Suv39h2 play a central role in the establishment of
constitutive heterochromatin and gene silencing.1-3 Pioneering
work demonstrated that the Suv39h1 and Suv39h2 histone
methyltransferases impose a tri-methylation mark on lysine-9 of
histone H3 (H3K9me3) which recruits members of the family of
Heterochromatin protein 1 (HP1) to establish the core structure
of constitutive heterochromatin at pericentric and telomeric
repeats.2,3 Lack of Suv39h HMTases in mice results in a com-
plete loss of H3K9me3 and HP1 at pericentric, telomeric and
subtelomeric repeats, submendelian birth-rates and impaired
chromosome segregation as well as an increased frequency of
spontaneous B cell lymphomas.4 Suv39h HMTases were also
demonstrated to silence intact LINE repeats in mouse embryonic
stem cells.5 Importantly, Suv39h HMTases were demonstrated
to act as central regulators of telomere length, underlining the rel-
evance of H3K9 methylation for the maintenance of genomic
stability.6-9 Telomeres are heterochromatic, nucleoprotein struc-
tures that ensure genome integrity by protecting chromosomes
from end-to-end fusions.10 Loss of telomere function results in
de-protection of chromosome ends that triggers a DNA damage
response leading to cell cycle arrest and senescence, hallmarks of
organismal aging.11 On the other hand, telomere dysfunction
increases cancer formation as a consequence of increased genomic
instability (for review 6,9). Several studies demonstrated that con-
stitutive heterochromatin acts as potent regulator of telomere
length in vertebrates, suggesting that telomere chromatin struc-
ture impacts on human aging and cancer.7-9 In particular, lack of
H3K9me3 at telomeres and subtelomeres drives recombination
between telomeric sister chromatids and leads to massive telo-
mere elongation without affecting chromosome end protec-
tion.7,8 Moreover, progressive telomere shortening is linked with
the loss of telomeric heterochromatin, including H3K9me3.8
This indicates that telomeric heterochromatin is not required for
chromosome end protection but has an important role in telo-
mere length regulation.7,9 Suv39h HMTases are also implicated
in de novo gene silencing. Retinoblastoma protein 1 was demon-
strated to recruit Suv39h1 in order to impose repressive H3K9
methylation at promoter regions of growth promoting E2F target
genes, thereby contributing to the establishment of cellular senes-
cence.12 Remarkably, Suv39h HMTases play a central role in the
establishment of foci enriched for H3K9me3 and HP1 in the
periphery of senescent but not quiescent cells, underlining a link
between Suv39h1 and senescence.13 Interestingly, induction of
lesions by the oncogenes Ras or BRAF is associated with
increased H3K9me3 and HP1 nuclear staining intensity and the
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expression of senescence markers. In line with this, loss of Suv39h
HMTases accelerates Ras or Myc driven tumorigenesis, indicat-
ing a central role of Suv39h HMTases in oncogene induced
senescence.14,15 Altogether, this indicates an intimate connection
of chromatin regulation with oncogene induced senescence in
pre-malignant lesions 14,16-20. The role of Suv39h HMTases in
cancer and telomere regulation has been extensively studied in
loss of function model systems.4 However, the effect of elevated
Suv39h HMTase expression on telomere regulation and tumor-
suppression during oncogenic stress has not yet been addressed in
gain of function models in vivo.
Here, we use a conditional Suv39h1 transgenic mouse model
system to study the role of Suv39h1 in telomere regulation, and
tumor induction using a DMBA/TPA (7,12-Dimethylbenz[a]
anthracene/12-O-tetradecanoylphorbol-13-acetate) skin carcino-
genesis protocol that is characterized by the accumulation of acti-
vating H-ras mutations.4 We demonstrate that elevated Suv39h1
expression significantly increases global H3K9me3 in the skin
and primary mouse embryonic fibroblasts of Suv39h1 transgenic
mice. Importantly, increased H3K9me3 at telomeres of Suv39h1
transgenic pMEFs is associated with a significant telomere short-
ening demonstrating that Suv39h1 is a negative regulator of telo-
mere length in embryo derived cells. Ectopic expression of
Suv39h1 increases the expression of p53 and its target genes Bax
and Puma and limits Ras/E1A induced immortalization of
Suv39h1 transgenic primary mouse embryonic fibroblasts
(pMEFs). In line with this, Suv39h1 transgenic mice are highly
resistant to DMBA/TPA driven skin carcinogenesis. DMBA/
TPA driven skin carcinogenesis is a process that involves the
accumulation of oncogenic H-Ras mutations, that are reported
to trigger oncogene-induced senescence.14,19 Our results show
that telomere length regulation is Suv39h1 dosage sensitive in
embryo derived cells and that increased Suv39h1 levels modulate
p53 tumorsuppressor pathway activity, thereby limiting transfor-
mation in the context of oncogenic stress or carcinogenesis. Our
results underline the relevance of telomeric heterochromatin for
the regulation of telomere length and suggest that Suv39h1 repre-
sents an interesting target to improve oncogene-mediated senes-
cence in pre-malignant lesions.
Results
Increased levels of global H3K9me3
in Suv39h1 overexpressing mice
In order to study the biological conse-
quences of Suv39h1 overexpression in vivo
we have generated conditional transgenic
mice. A construct containing the Suv39h1
cDNA downstream of a floxed transcrip-
tional stop-cassette (pA), that terminates
transgene-transcription driven from the
upstream located CAGGS promoter was
used to generate a transgenic mouse line
(Fig. 1A; see Material and Methods).
Transgenic mice were crossed with homo-
zygous CMV-Cre transgenic mice (ref. 21)
to obtain animals with excised transcrip-
tional stop-cassette (Suv39h1DStop/CMV-
Cre; in this study: “Suv39h1DStop” mice)
and heterozygous CMV-Cre mice (in this
study: “control”). To verify Cre-recombi-
nase mediated deletion of the transcrip-
tional stop-cassette, we have performed
southern blotting analysis using a specific
probe that discriminates between transgene
insertions before and after deletion of the
stop-cassette, but also detects the endoge-
nous Suv39h1 (Figure S1A). The excision
of the stop-cassette in pMEFs obtained
from Suv39h1 and Cre double transgenic
mice is highly variable, with a maximum
frequency of 98% (Figure S1A). Impor-
tantly, the efficiency of Cre-mediated dele-
tion of the stop-cassette correlates with
transgene expression, reaching a maximum
Figure 1. Suv39h1 transgenic mice. (A) Schematic representation of the Suv39h1 transgenic vec-
tor. Restriction sites for transgene-cassette excision and DNA gel blotting are indicated. (B)
Increased H3K9me3 expression levels in pMEFs obtained from control and Suv39h1DStop trans-
genic mice as determined by western blotting. Antibodies against global histone H3 were used to
control for equal loading. (C) Quantification of H3K9me3 levels shown in (B). H3K9me3 levels were
normalized to global histone H3 levels. (D) Suv39h1 expression levels in pMEFs derived from con-
trol and Suv39h1DStop transgenic mice as determined by western blotting using nuclear extracts
(pMEFs). Whole cell extracts prepared from H1299 transiently transfected with a control vector
(pcDNA) or HA-tagged Suv39h1 (HA-Suv39h1) were loaded to verify specificity of the anti-
Suv39h1 antibody. Weak Suv39h1 signals in Suv39h1DStop pMEFs are due to low antibody speci-
ficity. Arrows indicated specific Suv39h1 band; L.E.: long exposure, SE: short exposure. N D number
of different pMEF pool used for each genotype; standard deviations are indicated; a Student’s t-
test was used to calculate statistical significance.
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45-fold overexpression of Suv39h1 mRNA in primary mouse
embryonic fibroblasts (pMEFs) derived from Suv39h1DStop
embryos (Figure S1A, B). Consistent with the role of
Suv39h1 as histone H3 specific HMTase, pMEFs derived
from Suv39h1DStop embryos display significantly increased
levels of tri-methylated histone lysine-9 of histone H3
(H3K9me3; Fig. 1B, C; Figure S1C). This indicates that
Suv39h1 HMTase expressed from the transgenic construct is
enzymatically active.
Finally, western blotting using specific anti-Suv39h1 antibod-
ies confirmed ectopic expression of Suv39h1 in pMEFs obtained
from Suv39h1DStop embryos (Fig. 1D). Of note, Suv39h1D-
Stop animals were phenotypically normal and did not display
weight differences when compared to control mice (Figure S2A,
B).
We conclude that deletion of the floxed transcriptional stop-
cassette results in Suv39h1 transgene expression, and conse-
quently increased global levels of H3K9me3 in Suv39h1DStop
pMEFs.
Suv39h1 overexpression impacts on HP1b and increases
H3K9me3 in transgenic animals
We next wished to investigate the impact of Suv39h1
overexpression on chromatin structure in transgenic animals.
In line with western blotting experiments we found that
Suv39h1 overexpression correlates with a significant increase
of H3K9me3 staining intensity in the nuclei and at chromo-
centers of Suv39h1DStop pMEFs (Fig 2A, C). High-affinity
binding of HP1 proteins to H3K9me3 represents a key-step
in the formation of constitutive heterochromatin at pericen-
tric and telomeric repeats.2,7 To test whether ectopic
Suv39h1 impacts on the macroscopic structure of constitu-
tive heterochromatin we performed immunostainings for
HP1b and HP1g on Suv39h1DStop pMEFs. We found that
Suv39h1 overexpression changes dense HP1b staining at
DAPI rich chromocenters to a more dispersed staining pat-
tern; however increased Suv39h1 expression does not have
an obvious impact on HP1g staining pattern (Fig. 2B, D).
Remarkably, although H3K9me3 levels are efficiently
increased in Suv39h1DStop pMEFs, we did not find evi-
dence for a biologically relevant increase of HP1b or HP1g
levels in the nuclei of pMEFs from transgenic animals, as
detected by quantitative immunofluorescence (Fig. 2E, F).
We next wished to study the effect of Suv39h1 expression
on H3K9me3 levels in vivo. To validate the impact of
Suv39h1 transgene expression on chromatin structure we
measured global H3K9me3 levels on tail sections prepared
from adult Suv39h1DStop mice using confocal microscopy.
Consistent with data from pMEFs, we found significantly
increased levels of H3K9me3 in the nuclei of skin cells from
Suv39h1DStop transgenic mice (Fig. 2G, H). Together, this
indicates that Cre-mediated deletion of the stop cassette
results in Suv39h1 overexpression that increases global
H3K9me3 abundance and modulates the distribution of
nuclear HP1b, without affecting global HP1b and HP1g
levels.
Ectopic Suv39h1 expression drives telomere shortening
in pMEFs
We previously showed that Suv39h1 and Suv39h2 double
knock out (Suv39hDN) pMEFs and mouse embryonic stem cells
(mESCs) display a loss of chromatin compaction at telomeres
resulting in recombination dependent telomere elongation.7 This
indicates that telomeric chromatin structure is a major regulator
of telomere length.9 To investigate whether increased Suv39h1
expression impacts on telomere regulation we performed telo-
mere specific chromatin immunoprecipitation and telomere
length measurements. Consistent with immunofluorescence data,
we found that ectopic Suv39h1 expression causes an approxi-
mately 50% increase in H3K9me3 at telomeric and major satel-
lite repeats without affecting the abundance of HP1g or
H4K20me3 (Fig. 3A-D). As expected, Suv39h1 does not impact
on the abundance of TRF1 at telomeric TTAGGG repeats
(Fig. 3A, B).7 Performing quantitative DNA FISH using a fluo-
rescently labeled telomere repeat specific probe we found that
Suv39h1 overexpression results a significant overall telomere
shortening in Suv39h1DStop pMEFs when compared with con-
trol pMEFs (P < 0.0001; Fig. 3E, F). In line with this, we found
that Suv39h1 transgenic mice display an increased number of
short telomeres (< 30 kb) and reduced number of long telomeres
(>70 kb) (Fig. 3G). Our data is in line with the reported telo-
mere elongation in Suv39DN cells and underlines the role of
Suv39h1 as negative regulator of telomere length.7 Progressive
telomere shortening results in decreased subtelomeric DNA
methylation in telomerase knock-out pMEFs.8 However, the
modest telomere shortening in Suv39h1 overexpressing pMEFs
did not have an effect on subtelomeric DNA methylation (Fig.
S4). This suggests, that pronounced telomere shortening is
required to induce alteration in subtelomeric DNA methylation.
In contrast to Suv39h1DStop pMEFs that show a 10% reduction
of telomere length (Fig. 3E-G), we were not able to detect telo-
mere shortening in total skin or basal layer cells of these mice
(Figure S3A-C). We propose that rapid cell proliferation and
activation of various pathways involved in cell specification
events during adult skin formation can indirectly impact on telo-
mere homeostasis, thereby occulting the negative effect of
Suv39h1 on telomere length.
We conclude that Suv39h1 overexpression drives telomere
shortening in pMEFs obtained from transgenic mouse embryos,
underlining the role of Suv39h HMTases as negative regulator of
telomere length.
Suv39h1 transgenic mice are resistant to skin carcinogenesis
Recent data indicate a role for Suv39h1 in the control of pro-
liferation and maintenance of genomic stability. Suv39hDN
mice develop B cell lymphomas at increased frequency and have
a reduced capacity to activate a senescence program in response
to oncogenic stress.4,14 Moreover, Suv39h1 overexpression indu-
ces mitotic defects in human cancer cells and increases the
immortalization of primary erythroblasts.22,23 We next set out to
test a possible role of Suv39h1 in the control of cell proliferation
of primary cells and oncogene-induced transformation. To test
this idea we transduced primary fibroblasts derived from control
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and Suv39h1DStop embryos with retro-
viral expression vectors for E1A and H-
ras and performed colony forming
assays. Importantly, we found that
Suv39h1 transgene expression caused a
50% reduction of colony forming poten-
tial of E1A/H-ras transduced pMEFs
(Fig. 4A). This points toward a role of
Suv39h1 in antagonizing immortaliza-
tion driven by the Ras and E1A path-
ways. To identify a potential mechanism
that contributes to the increased resis-
tance to oncogenic transformation of
Suv39h1DStop pMEFs we examined the
p53 tumorsuppressor pathway in the
context of Suv39h1 overexpression. We
found that Suv39h1DStop pMEFs dis-
play a significant upregulation of p53
protein levels that is paralleled by upre-
gulation of p53 target genes Bax and
Puma (Fig. 4B, C) This suggests that
p53 is transcriptional active and that
increased tumor-surveillance by the p53
pathway can mediate increased resistance
to oncogenic transformation in
Suv39h1DStop pMEFs. This model is in
line with the central role of Suv39h1 and
p53 in mediating Ras-oncogene induced
senescence.14,24 In line with the data
from Suv39h1DStop pMEFs we found
that primary keratinocytes prepared
from the back skin of Suv39h1DStop
animals showed a significant, 25%
reduction in colony forming potential
compared to control cells (Fig. 4D). We
consequently wished to examine a poten-
tial tumor suppressive role of Suv39h1
in vivo. We decided to use a chemical
skin carcinogenesis protocol that involves
the acquisition of oncogenic mutations.
The DMBA/TPA protocol is a classic
tool to study chemical skin carcinogene-
sis that is driven by the accumulation of
oncogenic H-ras mutations.25 The back
skin of experimental mice was treated
with the DNA damaging agent DMBA,
followed by a repeated treatment with
the mitogen TPA for 29 weeks to pro-
mote the formation of neoplastic lesions
(Fig. 4E). As expected, control mice effi-
ciently develop papillomas during the
course of the experiment (Fig. 4F).
Importantly, Suv39h1DStop mice
exhibit a dramatically reduced frequency
of papilloma formation, indicating that
ectopic Suv39h1 expression confers
Figure 2. Suv39h1 overexpression increases H3K9me3 in transgenic pMEFs and animals: (A)
Increased nuclear H3K9me3 levels in pMEFs obtained from control and Suv39h1DStop transgenic
mice as determined by automated confocal microscopy. (B) Quantification of confocal H3K9me3
immunofluorescence of samples shown in (A) Suv39h1 overexpression results in a significant increase
in H3K9me levels. (C) Suv39h1 overexpression results in a re-distribution of HP1b in pMEFs, as deter-
mined by immunofluorescence staining. (D) Suv39h1 does not impact on the localization of HP1g, as
determined by immunofluorescence staining. (E) Suv39h1 overexpression does not impact on global
HP1b levels in Suv39h1DStop pMEFs, as determined by classic quantitative immunofluorescence.
Left panel: quantification; right panel, representative images. (F) Suv39h1 overexpression does not
impact on global HP1g levels in Suv39h1DStop pMEFs, as determined by automated confocal quanti-
tative immunofluorescence. Left panel: quantification; right panel, representative images. (G)
Immuno-histochemistry on adult skin sections using H3K9me3 specific antibodies. Suv39h1DStop
mice display increase H3K9me3 levels as demonstrated by confocal microscopy and signal intensity
mapping (see material methods). H3K9me3 intensity ranges are indicated by a color code that is
based on arbitrary telomere fluorescence units. (H) Quantification of average H3K9me3 intensity.
Average H3K9me3 levels are significantly increased in tail skin sections of Suv39h1DStop mice. N D
number of independently prepared pMEF cultures or mice tested; n D number of nuclei analyzed;
arbitrary fluorescence intensity values are indicated; standard deviations are indicated; p-values indi-
cate statistical significance.
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resistance to DMBA/TPA induced carcino-
genesis (Fig. 4F). This indicates that
increased Suv39h1 expression levels confers
increased tumor protection in transgenic
mice. Together our data suggest that
ectopic Suv39h1 expression increases p53
protein expression to mediate improved
tumorsuppression under conditions involv-
ing oncogenic stress.
Discussion
The histone H3K9 specific histone
methyltransferases Suv39h1 and Suv39h2
are essential for the formation of constitu-
tive heterochromatin at pericentric and
telomeric repeats but are also critically
involved in the silencing of gene expres-
sion.3,12 In particular, Suv39h1 has an
important role in mediating the irreversible
silencing of cell cycle promoting E2F genes
to promote senescence in primary cells but
also Ras-oncogene mediated senescence in
premalignant tumors.13,14 Lack of
Suv39h1 and Suv39h2 results in genomic
instability and loss of telomeric heterochro-
matin leading to an uncontrolled telomere
elongation.4,6 Here, we use a transgenic
mouse model system to investigate the
effect of increased Suv39h1 levels in the
context of telomere regulation and chemi-
cal oncogenesis. In contrast to a previously
reported Suv39h1 transgenic mouse model
(ref. 23) Suv39h1DStop mice did not dis-
play alterations in body-weight. We suggest
that this discrepancy is due to the variable
efficiency of Cre-mediated deletion of the
transcriptional Stop cassette in our mouse
model system (Fig. S1A, B).
Consistent with the telomere elongation
phenotype in Suv39h DN pMEFs and
mESCs (ref. 7), we observed that increased
telomeric and global H3K9me3 levels drive
telomere shortening in pMEFs obtained
from Suv39h1 transgenic mice. Interest-
ingly, increased H3K9me3 levels were not
paralleled by increased levels of nuclear
HP1g and HP1b or enrichment of HP1g
at telomeres. We speculate that the moder-
ate increase of H3K9me3 in Suv39h1
transgenic mice is not sufficient to increase
the recruitment of HP1g to constitutive heterochromatin. Our
results demonstrate that H3K9me3 abundance is an efficient reg-
ulator of telomere length in embryo-derived cells. However, we
were not able to link an increased H3K9me3 with telomere
shortening in adult tail skin sections. We speculate that cell pro-
liferation coupled with various cell differentiation pathways that
control skin formation might also impact on the expression of
telomere regulators and thereby over-ride telomere shortening
Figure 3. Compaction of telomeric chromatin and telomere shortening in Suv39h1DStop pMEFs.
(A) Suv39h1DStop pMEFs display augmented H3K9me3 levels at telomeric repeats, as determined
by ChIP. Representative images are shown. (B) Quantification of immunoprecipitated telomeric
DNA using the indicated antibodies; signals were normalized to the input material. (C) Suv39h1D-
Stop pMEFs display augmented H3K9me3 levels at pericentric major satellite repeats. Representa-
tive images are shown. (D) Quantification of immunoprecipitated major satellite repeats; signals
were normalized to the input material. (E) Quantitative telomere Q-FISH on metaphase chromo-
somes obtained from control and Suv39h1DStop pMEFs. Suv39h1DStop transgenic pMEFs (right
panel) display overall telomere shortening when compared to control littermates (left panel). (F)
Average telomere length is significantly shorter in Suv39h1DStop transgenic mice when compared
to pMEFs with normal Suv39h1 expression. (G) Accumulation of short telomeres (<30 kb) and
reduction of long (>70 kb) upon Suv39h1 overexpression in Suv39h1DStop pMEFs. N, number of
independently prepared pMEF cultures analyzed; standard deviations are indicated; n, number of
telomeres analyzed; statistical significance is indicated by p-values
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caused by Suv39h1 overexpression in embryo-derived fibroblasts.
Suv39h1 overexpression has been reported to de-localize HP1b
and to impair proliferation of cancer cells.22 In addition, a previ-
ous study show that Suv39h1 overexpression can increase p53
expression.23 Here, we found that ectopic
Suv39h1 confers increased resistance to
oncogenic stress conditions. In particular
we show that pMEFs obtained from
Suv39h1DStop embryos display signifi-
cantly increased p53 protein levels. The
fact that p53 target gene Bax and Puma are
upregualted in Suv39h1DStop pMEFs sug-
gest that p53 is transcriptional active,
indicative for increased tumor surveillance.
Elevated basal p53 tumorsuppressor activ-
ity in Suv39h1DStop pMEFs offers an
attractive model to explain the increased
resistance of Suv39h1DStop pMEFs to
oncogenic transformations mediated via
E1A/H-ras. This is in line with a study that
demonstrates that loss of Suv39h1 or p53
impairs oncogene induced senescence, a
key tumorsuppressive mechanism in pre-
malignant lesions.14,24 In line with
increased resistance to E1A/H-ras induced
transformation we found that Suv39h1D-
Stop transgenic animals display a remark-
able resistance to DMBA/TPA mediated
skin carcinogenesis, a process that has been
demonstrated to involve the acquisition of
oncogenic H-ras mutations.25 We propose
that Suv39h1 dependent increase of basal
expression levels of p53 protein as observed
in Suv39h1DStop pMEFs provides a
model to explain increased resistance to
chemical carcinogenesis of Suv39h1 over-
expressing animals. This model is sup-
ported by the reported loss of oncogene
induced senescence in the absence of p53
and Suv39h1, but also by the fact that a
modest increase in p53 protein levels in
Super-p53 mice is sufficient to mediate
increased resistance to 3MC chemical
carcinogenesis.14,24,26
Altogether, our transgenic mouse model
underlines the role of the Suv39h1
HMTase as negative regulator of telomere
length and identifies Suv39h1 as an inter-
esting target modulate p53 tumorsuppres-
sor activity and improving resistance to
oncogene induced transformation.
Material and Methods
Generation of transgenic animals
and cell culture
Human non-small cell lung carcinoma H1299 cells were
obtained from ATCC and have not been cultured for longer
than 6 months. pMEFs and H1299 cells were cultured in
Figure 4. Suv39h1 overexpression limits immortalization and confers resistance to skin carcino-
genesis. (A) Colony forming assay of control and Suv39h1DStop transgenic pMEFs after retroviral
transduction of H-ras and E1A. Suv39h1 overexpression results in reduced immortalization as indi-
cated by limited colony formation potential. Color code indicates diameter of formed colonies
(mm). (B) Left panel: western blotting indicates elevated p53 protein levels in Suv39h1DStop
pMEFs. Actin was used as a loading control. Right panel: quantification of western blotting results.
(C) Quantitative real-time PCR of p53 target genes Bax and Puma. Actin was used to normalize
expression levels. (D) Colony forming assays using primary mouse keratinocytes prepared from
the back skin of control or Suv39h1DStop newborn mice. Suv39h1DStop keratinocytes display
reduced colony forming potential. Color code indicates diameter of formed colonies (mm). (E)
Schematic representation of the DMBA/TPA skin carcinogenesis protocol. After an initial DMBA
treatment, the back skin of experimental mice was treated twice per week with TPA for a total
period of 15 weeks. Papilloma formation and size was monitored in weekly inspections. (F) Papil-
loma formation in control and Suv39h1DStop mice during DMBA/TPA skin carcinogenesis. Papil-
loma formation is efficiently impaired in Suv39h1DStop mice. Color code indicates diameter of
formed papillomas (mm). N, number of mice or independently prepared cell cultures analyzed; n,
number of total numbers of experiments or replicas analyzed; standard deviations are indicated;
statistical significance is indicated by p-values.
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DMEM high glucose (Life Technologies), 10% heat-inactivated
FBS (Gibco). H1299 cells were transiently transfected with
pcDNA and pcDNA-HA-Suv39h1 using Lipofectamine 2000
(Life Technologies) according to the manufacturer’s suggestions.
To prepare a vector for transgene injection, the coding region
of the murine Suv39h1 ORF was amplified by PCR and cloned
downstream of a CAGGS promoter, a transcriptional Stop cas-
sette, flanked by loxP sites and upstream of a transcriptional ter-
mination cassette (Figure S1A).27 Constructs were verified by
DNA sequencing. The CMV-loxP-Stop-loxP-Suv39h1-pA cas-
sette was excised from the vector using PvuII/SalI, purified and
injected into the pronuclei of fertilized oocytes obtained from
C57BL/6 £ CBA F1 mice at the CNIO transgenics unit and
founder mice were established. Founder animals were back-
crossed for 3 generations to a pure C57BL/6 background to
obtain the Suv39h1 transgenic line studied here. Germline trans-
mission of the transgene was verified by Southern blotting using
a Suv39h1 cDNA probe that detects the Suv39h1 transgene but
also endogenous Suv39h1 locus (Fig. 1A). Suv39h1Stop trans-
genic animals were crossed with homozygous CMV-Cre recom-
binase transgenic animals (ref. 21) to give rise to Suv39h1DStop-
CMV-Cre mice (in this study: Suv39h1DStop) and heterozygous
CMV-Cre (in this study “control” mice) offsprings. A PCR strat-
egy was developed that allows the detection of the transgene
before and after Cre-recombinase mediated deletion of the loxP-
Stop-loxP cassette (primer sequences available upon request). In
pMEFs deletion of the loxP-Stop-loxP cassette was verified by
Southern blotting and PCR (Figure S1A). Transgene expression
was confirmed by quantitative real-time PCR. Mice were gener-
ated and maintained at the CNIO under specific-pathogen-free
conditions in accordance with the recommendations of the Fed-
eration of European Laboratory Animal Science Associations. All
efforts were made to minimize suffering.
Skin carcinogenesis
Age-matched (8- to 12-wk-old) mice of each genotype (37
control; 6 Suv39h1DStop) were shaved and treated with a single
dose of DMBA (7,12-Dimethylbenz[a]anthracene; 0.1 mg/mL
in acetone; Sigma). Mice were subsequently treated twice weekly
with TPA (12-O-tetradecanoylphorbol-13-acetate; 12.5 mg in
200 mL of acetone each treatment; Sigma) for 15 wk. Papilloma
formation and growth was followed in weekly examinations dur-
ing additional 15 weeks (Fig. 4E, F) 25,28.
Telomere length analyses on tail skin sections and pMEF
metaphase spreads
Paraffin-embedded skin sections were de-paraffinated and
hybridized with a PNA-telomeric probe, and telomere fluores-
cence was determined by confocal microscopy and telomapping.
Telomapping is based on confocal telomere quantitative fluores-
cence in situ hybridization that allows to detect gradients of telo-
mere length within tissues or cell populations.29 This technique
can be adopted to immunostainings. For telomere Q-FISH on
metaphase spreads exponentially growing primary mouse embry-
onic fibroblasts (pMEFs) were incubated with 0.1 mg/mL colce-
mid (GIBCO) for 5 h at 37C and then fixed in methanol:acetic
acid (3:1). Q-FISH was performed as described.30 Images were
captured in a linear acquisition mode using a COHU CCD cam-
era on a Leica DMRB microscope.
Immunohistochemistry
Skin samples were fixed in 10% buffered formalin, embedded
in paraffin wax and sectioned at 4 mm. After de-paraffination,
sections were processed with 10 mM sodium citrate (pH 6.0) for
20 min at 95C. After blocking in 5% goat serum cells were
incubate with respective primary and secondary antibodies.
Immnofluorescence stainings on pMEFs were carried out as pre-
viously described.31 Following primary antibodies were used: a
rabbit anti-H3K9me3 antibody (Upstate 07–442); a mouse
monoclonal anti-HP1g specific antibody (Upstate 05–690), or a
rabbit polyclonal anti-HP1b specific antibody (abcam 10478).
Primary antibodies were incubated for 1 hour at room tempera-
ture. Secondary Cy3-goat anti-rabbit antibody (1:400; Jackson
Immuno Research Laboratories, Inc.) and a FITC-goat anti-
mouse antibody (1:400; Jackson ImmunoResearch Laboratories,
Inc.) for 60 min at room temperature; slides were mounted in
Vectashield with 40,6-diamino-2 phenylindole. Quantitative
image analysis of immunostainings (4’,6-diamidino-2-phenylin-
dole) of pMEFs and mouse tail skin sections was performed by
confocal microscopy (H3K9me3 and HP1g mapping) using a
TCS-SP2-A-OBS-UV Leica microscope with Metamorph soft-
ware (version 6.3r6) platform or by classic quantitative immuno-
fluorescence (Zeiss Axiovert 200 M microscope, equipped with a
Zeiss AxioCam MRm digital camera and AxioVision Rel. 4.8
imaging software followed by ImageJ picture analysis), as previ-
ously described.29,31,32
Isolation, culture and colony forming assays using primary
mouse keratinocytes
Skin keratinocyes were isolated from the back skin of newborn
mice as described. For colony forming assays 104 or 5 £ 105 ker-
atinocytes were seeded on a mitomycin C treated J2-3T3 feeder
layer and cultivated in CnT-O2 medium with supplement and
antibiotics (CELLnTEC, Advanced Cell Systems AG) for 11 d
Subsequently cells were fixed with 18,5% formaldehyde and
stained in with 1% Rhodamine B. Colony size and numbers
were assessed.
Western blots
Whole cell and nuclear extract was prepared as previously
described.31 Extracts were separated on SDS–polyacrylamide
gels. After transfer, the membranes were incubated with an anti-
H3K9me3 polyclonal antibody (Upstate, 07–442), anti-
Suv39h1 monoclonal antibody “. . .(Abcam ab1791), a poly-
clonal rabbit anti-Bax antibody (Cell signaling 2772), mouse
monoclonal anti-p53 antibody (abcam [PAb 240] (ab26)), goat
polyclonal anti Lamin A/C antibody (Santa Cruz (N18): sc-
6215) or polyclonal anti-global histone H4 antibodies (Abcam,
ab10158). Antibody binding was detected after incubation with
a secondary antibody coupled to horseradish peroxidase.
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Chromatin Immunoprecipitation (ChIP)
Chromatin immunoprecipitation of telomeric and subtelo-
meric chromatin was performed as previously described.7 The
following antibodies were used for immunoprecipitation: poly-
clonal rabbit anti-mouse TRF1 (produced in house), a monoclo-
nal anti-HP1g antibody (Upstate, 05–690), a polyclonal rabbit
anti-H3K9me3 antibody (Upstate 07–442) and a polyclonal rab-
bit anti-H4K20me3 antibody (Upstate 07–749). DNA was puri-
fied from immunoprecipitated chromatin, transferred to a
nitrocellulose membrane and probed with a radio labeled telo-
meric or major satellite probe. Signal intensities were quantified
using ImageJ and normalized to the ChiP Input.
Quantitative real-time PCR
Total RNA was prepared using QIAzol Lysis Reagent (Qia-
gen) and reverse transcribed with QuantiTect Reverse Transcrip-
tion Kit (Qiagen) according to the manufacturer’s instructions.
Quantitative PCR was performed using the QuantiFast SYBR
Green PCR Kit (Qiagen) and analyzed with the CFX96 Real-
Time PCR Detection System (BIO-RAD). mRNA levels were
normalized to actin. PCR primers used for quantitative Real-
Time PCR (ref.33): Bax FW: 50 GGAGCAGCTTGGGAGCG
30, Bax REV: 50 AAAAGGCCCCTGTCTTCA 30; Puma FW:
50 ACCTCAACGCGCAGTAC 30, Puma REV: 50 TGAGG
GTCGGTGTCGAT 30; b-actin FW: 50 CACACCCGCCAC-
CAGTTC 30, b-actin REV: 50 CCCATTCCCACCATCA-
CACC 30.
Bisulfite sequencing
Bisulfite sequencing of subtelomeric regions in Chr1q and
Chr2q and B1SINE repeats was carried out as described
previously.7
Colony formation assays using pMEFs
Low passage of pMEFs of control and Suv39h1DStop trans-
genic mice were infected with a recombinant, replication defi-
cient retroviral vector expressing E1A and H-ras as previously
described.34 Puromycin selection for 3 d was used to eliminate
non-transduced cells. After 19 d colonies were stained with
Giemsa and colony number and size was determined. pMEFs
were cultured in DMEM, high glucose; 10% fetal bovine serum;
L-glutamine and Pen/Strep (all Invitrogen).
Statistical analysis
The Wilcoxon–Mann–Whitney rank sum test was used for
statistical comparisons of the mean telomere length in MEFs.
For all other experiments a Student’s t-test was used to calculate
statistical significance.
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